Cellorgane® Multi-Complex 3G Formula 7 Brain-Hypothalamus-Pituitary
Central Nervous System
With age, organ function progressively decreases due to cell deterioration, caused mainly by oxidative stress; this generates vitality and quality of life losses.
This organic sub function predisposes to chronic degenerative diseases.
Damage by oxidative stress, chronic diseases, neurological cognitive deficiencies.
Migraine, Headache, Neuralgia, Sciatica, Depressive States, Acute and Chronic Stress, Diabetes Mellitus type II, lack of concentration and memory, Alzheimer and Parkinson
initial stages, Attention Deficit Disorder (ADD) in adult patients and Aging.
The contribution of cellular cytokines and growth factors in embryonic extracts has a refreshing and revitalizing effect at the cellular level, which increases the specific functionality of the organ to be treated.
Antioxidant enzymes neutralize free radicals, thereby reducing damage from oxidative stress.
Oral CELLORGANE 7
Each 500-mg enteric coated tablet contains:
Opotherapic cell extracts: Brain 15%, Hypothalamus 15%, Pituitary 15%, 10% formulated Enzyme Therapy 10%, embryonic ectoderm 10%, Thymus 10%, Placenta 10%; Glutamic Acid 2%, Phosphatidylserine 1%, Zymocell complex enzyme, superoxide dismutase, glutathione peroxidase, glutathione reductase, glutathione transferase; stabilizers and Maltodextrin 11%.
Formula components reach the cells directly or indirectly, in the case of oral products, by bloodstream, and are selectively incorporated into the cells through various means of cellular transport.
It acts revitalizing the nervous system at the cellular level, improving its functionality and reducing the risk of degenerative diseases
- Allergies to animal proteins.
- Allergy to any of its components.
- Pregnancy and lactation.
Neuralgia, Diabetes Mellitus type II, Alzheimer's, Parkinson's and Sciatica
Two tablets in the morning and 2 at night, for at least six months.
Migraine, Headache, Neuralgia, Depressive States, Acute and Chronic Stress, lack of concentration and memory, Attention Deficit Disorder (DDA) in adult patients
Two tablets in the morning and 2 at night, for at least three months.
The tablets are taken in the morning on an empty stomach and at night before dinner (30 minutes before meals).
The dose may be increased according to the clinical picture of the patient and the physician's discretion; the results depend on the completion of treatment.